FDA Adverse Event and Medication Error Reports

The FDA Adverse Event Reporting System (FAERS) database supports post-marketing safety surveillance for drugs and biologics. It contains adverse event and medication error reports submitted to the FDA, with data updated quarterly.

Use Cases

• Identify potential drug safety signals by analyzing patterns in adverse event reports.
• Monitor medication error trends from submitted reports to inform risk management strategies.
• Support pharmacovigilance research by studying reported adverse events for therapeutic biologic products.

Strengths

• Data is updated quarterly, providing recent information for safety surveillance.
• Reports are submitted to the FDA, an authoritative regulatory body.
• Covers both drug and therapeutic biologic products.

Limitations

• Report data is voluntary and may not reflect the true incidence of adverse events.
• The dataset likely contains unstructured text fields that require significant preprocessing for analysis.
• Specific data volume (row count) and structure (column count) are not provided in the input.

Provenance

Source

U.S. Department of Health & Human Services, FDA.

Collection Method

Reports submitted to the FDA.

Freshness

Updated quarterly; last updated July 2025.

Geography

Primarily United States, but may include international reports.